Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADRB2 | P07550 | 19/20 | 0.61 |
| ▸ | ADRB1 | P08588 | 7/20 | 0.61 |
| ▸ | ADRB3 | P13945 | 5/20 | 0.61 |
| ▸ | PGR | P06401 | 1/20 | 0.38 |
| ▸ | DRD2 | P14416 | 1/20 | 0.38 |
| ▸ | SLC6A4 | P31645 | 1/20 | 0.38 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.38 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.38 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL375931 | 0.91 | ADRB2 (0.74) | ADRB2ADRB1ADRB3 | |
| SCHEMBL5968418 | 0.87 | ADRB2 (0.59) | ADRB2ADRB1ADRB3PGRDRD2 | |
| SCHEMBL2006825 | 0.84 | ADRB2 (0.85) | ADRB2ADRB1ADRB3 | |
| SCHEMBL2006826 | 0.84 | ADRB2 (0.85) | ADRB2ADRB1ADRB3 | |
| SCHEMBL2006829 | 0.84 | ADRB2 (0.85) | ADRB2ADRB1ADRB3 | |
| Hydrochloric Acid SCHEMBL2006113 | 0.83 | ADRB2 (0.84) | ADRB2ADRB1ADRB3 | |
| Hydrochloric Acid SCHEMBL2006112 | 0.83 | ADRB2 (0.84) | ADRB2ADRB1ADRB3 | |
| Hydrochloric Acid SCHEMBL2006109 | 0.83 | ADRB2 (0.84) | ADRB2ADRB1ADRB3 | |
| SCHEMBL6141542 | 0.79 | ADRB2 (0.58) | ADRB2ADRB1ADRB3PGRDRD2 | |
| SCHEMBL375125 | 0.77 | ADRB2 (0.57) | ADRB2ADRB1ADRB3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1687257-A2 | AMINO-SUBSTITUTED ETHYLAMINO &Bgr;2 ADRENERGIC RECEPTOR AGONISTS | Theravance, Inc. (US) | 2006-08-09 | — | — | EP | disclosed |
| WO-2005030678-A2 | AMINO-SUBSTITUTED ETHYLAMINO β2 ADRENERGIC RECEPTOR AGONISTS | THERAVANCE, INC. (US) | 2005-04-07 | — | — | WO | disclosed |